PFIZER / NSE / Major Drugs

Pfizer

INR 4,460-49.20 (0.81%) 1D

Last updated: 2026-06-16T10:36:37.764624+00:00

Price Chart

1Y Price Trend

Open5,910

High5,993

Low4,396.7

Close4,518

Volume13,432

Change-1,392

Change %-23.55%

Key Information

Ticker SymbolPFIZER

Current Price4,460

52-Week High5,873.5

52-Week Low4,415

Market Cap20,383.6

Beta0.64

Volume13,432

ISININE182A01018

Day High4,577.9

Day Low4,511

Open4,548.9

Recommendations

RatingStrong Buy

Target High5,878.55

Target Low4,412.8

Target Mean1.6

Target Median75

Risk Metrics

Overall RiskBalanced risk

Board Risk25.81

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Pfizer Ltd stock (INE182A01018): India earnings and dividend keep investors watching - AD HOC NEWS8 days ago

Market news

Pfizer Ltd stock (INE182A01018): India earnings and dividend keep investors watching AD HOC NEWS

PFIZER LTD Share Price Today - Live PFIZER Stock Price for NSE/BSE - Upstox12 days ago

Market news

PFIZER LTD Share Price Today - Live PFIZER Stock Price for NSE/BSE Upstox

Markets Rally, But Pfizer Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off - Markets Mojo13 days ago

Market news

Markets Rally, But Pfizer Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off Markets Mojo

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo13 days ago

Market news

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals Markets Mojo

Pfizer launches new myeloma therapy in India, targeting patients with limited options - Moneycontrol.com13 days ago

Market news

Pfizer launches new myeloma therapy in India, targeting patients with limited options Moneycontrol.com

Five Consecutive Losses Push Pfizer Ltd. to a New 52-Week Low - Markets Mojo13 days ago

Market news

Five Consecutive Losses Push Pfizer Ltd. to a New 52-Week Low Markets Mojo

Pfizer Ltd. Q4 FY26: Modest Growth Amid Margin Recovery, But Valuation Concerns Persist - Markets Mojo14 days ago

Market news

Pfizer Ltd. Q4 FY26: Modest Growth Amid Margin Recovery, But Valuation Concerns Persist Markets Mojo

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure - Markets Mojo20 days ago

Market news

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure Markets Mojo